Drugs that are being tested but are not yet approved are called investigational (or experimental) drugs and patients can get access in two ways:
- They can participate in the drug testing process, known as a clinical trial, or
- They can be given the drug as part of a special program, more formally known as expanded access.
In general, to obtain access to a drug that is in testing but has not yet been approved, a patient must meet the entrance criteria and volunteer to participate in a clinical study of the drug. More information about ongoing clinical trials is available at ClinicalTrials.gov.
Sometimes, people with serious or immediately life-threatening illnesses cannot wait until a drug that could possibly help them stay alive is approved. In some of these cases, FDA authorizes the manufacturer to provide patients with access to a drug that is still being tested for safety and effectiveness but is not yet approved.
FDA does not create expanded access programs; these programs are created by the drug’s manufacturer, sometimes at the request of a doctor whose patient is in urgent need of the medication. If there is no established expanded access program in effect for which the patient qualifies, FDA can consider a request for expanded access on a case-by-case basis.
- FDA Basics Webinar: "Mini-Sentinel," FDA's New Tool for Monitoring the Safety of FDA-Approved Medical Products
- FDA Webinar on Prescription Drug Shortages
- Where can I find information about adverse reactions to a medicine prescribed for my child?
- Where can I find information about medicines prescribed for my child?
- Materials from Webinar on Access to Investigational Drugs
- FDA Webinar on "Bad Ads" Program
- FDA Basics Webinar on Generic Drugs
- What are over-the-counter (OTC) drugs and how are they approved?
- How FDA Evaluates Regulated Products: Drugs
- What is counterfeit medicine?
- How can I stay better informed about drugs? Is there a reliable website FDA recommends?
- What is an FDA Drug Safety Communication?
- How do I discard medicine that I no longer need, do I just throw it in the garbage?
- What are unapproved drugs and why are they on the market?
- How do I report a bad reaction to medicine or medication error to FDA?
- Does FDA approve the proprietary names of prescription drugs?
- What does FDA require drug manufacturers to do to prevent contaminated drugs? If contamination occurs, how must they correct the problem?
- How does FDA help consumers when drug shortages happen?
- Can FDA ban direct-to-consumer drug advertising?
- How does FDA oversee domestic and foreign drug manufacturing?
- Why isn’t a drug taken off the market when a manufacturer gets a Warning Letter?
- What is a Warning Letter?
- How does FDA decide when a drug is not safe enough to stay on the market?
- Does FDA approve the information given out by pharmacies when I pick up my medicine?
- Why do some drug labels get changed so often ?